PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-11.20%
Both companies show declining revenue. Martin Whitman would check for industry-wide issues.
-6.95%
Cost reduction while VET shows 18.79% growth. Joel Greenblatt would examine competitive advantage.
-18.65%
Both companies show declining gross profit. Martin Whitman would check industry conditions.
-8.39%
Both companies show margin pressure. Martin Whitman would check industry conditions.
No Data
No Data available this quarter, please select a different quarter.
-75.71%
G&A reduction while VET shows 5.56% growth. Joel Greenblatt would examine efficiency advantage.
96.39%
Marketing expense change of 96.39% while VET maintains spending. Bruce Berkowitz would investigate effectiveness.
10.75%
Other expenses growth while VET reduces costs. John Neff would investigate differences.
-4.42%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
-6.72%
Both companies reducing total costs. Martin Whitman would check industry trends.
-6.67%
Both companies reducing interest expense. Martin Whitman would check industry trends.
1.78%
D&A growth while VET reduces D&A. John Neff would investigate differences.
-36.70%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
-1.27%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-21.71%
Operating income decline while VET shows 71.88% growth. Joel Greenblatt would examine position.
-11.84%
Operating margin decline while VET shows 93.83% growth. Joel Greenblatt would examine position.
45.45%
Other expenses growth less than half of VET's 99.34%. David Dodd would verify if advantage is sustainable.
-59.89%
Pre-tax income decline while VET shows 106.05% growth. Joel Greenblatt would examine position.
-54.83%
Pre-tax margin decline while VET shows 106.82% growth. Joel Greenblatt would examine position.
-57.35%
Tax expense reduction while VET shows 147.39% growth. Joel Greenblatt would examine advantage.
-60.51%
Net income decline while VET shows 100.29% growth. Joel Greenblatt would examine position.
-55.53%
Net margin decline while VET shows 100.32% growth. Joel Greenblatt would examine position.
-60.19%
EPS decline while VET shows 100.29% growth. Joel Greenblatt would examine position.
-60.13%
Diluted EPS decline while VET shows 100.29% growth. Joel Greenblatt would examine position.
-0.95%
Both companies reducing share counts. Martin Whitman would check patterns.
-1.13%
Diluted share reduction while VET shows 0.05% change. Joel Greenblatt would examine strategy.